サマリー

世界のインフルエンザワクチン市場 2023-2027
インフルエンザワクチン市場は、2022-2027年に29億3388万米ドルの成長が予測され、予測期間中のCAGRは6.89%で加速すると予測されます。当レポートでは、インフルエンザワクチン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、インフルエンザの流行と発症率の増加、インフルエンザワクチン接種に対する意識の高まり、予防接種プログラムや研究活動の開始によって牽引されています。
Technavioのインフルエンザワクチン市場は以下のように区分されています：
流通チャネル別
- 病院および薬局
- 政府機関
- その他
タイプ別
- 弱毒生インフルエンザワクチン
- 遺伝子組み換えインフルエンザワクチン
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるインフルエンザワクチン市場の成長を促進する主な理由の1つとして、再接種の必要性を挙げています。また、インフルエンザウイルスの遺伝子解析研究の急増や世界的な旅行者の増加も、市場の大きな需要につながるでしょう。
本レポートでは、インフルエンザワクチン市場について以下の領域をカバーしています：
- インフルエンザワクチン市場のサイジング
- インフルエンザワクチン市場予測
- インフルエンザワクチン市場産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、Altimmune Inc、AstraZeneca PLC、Baxter International Inc.、BioDiem Ltd.、BiondVax Pharmaceuticals Ltd.、CSL Ltd.、Emergent BioSolutions Inc.、F. Hoffmann La Roche Ltd.、FluGen Inc.、GlaxoSmithKline Plc.、Mitsubishi Chemical Group Corp.、Novavax Inc.、Otsuka Holdings Co.Ltd.、ファイザーInc.、サノフィSA、石家荘易嶺製薬有限公司、SKケミカルズCo.Ltd.、Vaccitech Plc.、Vaxart Inc.また、インフルエンザワクチン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/influenza-vaccine-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global influenza vaccine market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global influenza vaccine market 2017 - 2021 ($ million)
o 4.2 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospitals and pharmacies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
o 6.4 Government and institutional - Market size and forecast 2022-2027
o Exhibit 38: Chart on Government and institutional - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Government and institutional - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Government and institutional - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Government and institutional - Year-over-year growth 2022-2027 (%)
o 6.5 Others - Market size and forecast 2022-2027
o Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Live attenuated influenza vaccines - Market size and forecast 2022-2027
o Exhibit 52: Chart on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
o 7.4 Recombinant influenza vaccines - Market size and forecast 2022-2027
o Exhibit 56: Chart on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Type
o Exhibit 60: Market opportunity by Type ($ million)
o Exhibit 61: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 India - Market size and forecast 2022-2027
o Exhibit 99: Chart on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Altimmune Inc.
o Exhibit 111: Altimmune Inc. - Overview
o Exhibit 112: Altimmune Inc. - Product / Service
o Exhibit 113: Altimmune Inc. - Key news
o Exhibit 114: Altimmune Inc. - Key offerings
o 12.4 AstraZeneca PLC
o Exhibit 115: AstraZeneca PLC - Overview
o Exhibit 116: AstraZeneca PLC - Product / Service
o Exhibit 117: AstraZeneca PLC - Key news
o Exhibit 118: AstraZeneca PLC - Key offerings
o 12.5 Baxter International Inc.
o Exhibit 119: Baxter International Inc. - Overview
o Exhibit 120: Baxter International Inc. - Business segments
o Exhibit 121: Baxter International Inc. - Key news
o Exhibit 122: Baxter International Inc. - Key offerings
o Exhibit 123: Baxter International Inc. - Segment focus
o 12.6 BiondVax Pharmaceuticals Ltd.
o Exhibit 124: BiondVax Pharmaceuticals Ltd. - Overview
o Exhibit 125: BiondVax Pharmaceuticals Ltd. - Product / Service
o Exhibit 126: BiondVax Pharmaceuticals Ltd. - Key offerings
o 12.7 CSL Ltd.
o Exhibit 127: CSL Ltd. - Overview
o Exhibit 128: CSL Ltd. - Business segments
o Exhibit 129: CSL Ltd. - Key news
o Exhibit 130: CSL Ltd. - Key offerings
o Exhibit 131: CSL Ltd. - Segment focus
o 12.8 FluGen Inc.
o Exhibit 132: FluGen Inc. - Overview
o Exhibit 133: FluGen Inc. - Product / Service
o Exhibit 134: FluGen Inc. - Key offerings
o 12.9 GlaxoSmithKline Plc
o Exhibit 135: GlaxoSmithKline Plc - Overview
o Exhibit 136: GlaxoSmithKline Plc - Business segments
o Exhibit 137: GlaxoSmithKline Plc - Key news
o Exhibit 138: GlaxoSmithKline Plc - Key offerings
o Exhibit 139: GlaxoSmithKline Plc - Segment focus
o 12.10 Mitsubishi Chemical Group Corp.
o Exhibit 140: Mitsubishi Chemical Group Corp. - Overview
o Exhibit 141: Mitsubishi Chemical Group Corp. - Business segments
o Exhibit 142: Mitsubishi Chemical Group Corp. - Key offerings
o Exhibit 143: Mitsubishi Chemical Group Corp. - Segment focus
o 12.11 Novavax Inc.
o Exhibit 144: Novavax Inc. - Overview
o Exhibit 145: Novavax Inc. - Product / Service
o Exhibit 146: Novavax Inc. - Key offerings
o 12.12 Pfizer Inc.
o Exhibit 147: Pfizer Inc. - Overview
o Exhibit 148: Pfizer Inc. - Product / Service
o Exhibit 149: Pfizer Inc. - Key news
o Exhibit 150: Pfizer Inc. - Key offerings
o 12.13 Sanofi SA
o Exhibit 151: Sanofi SA - Overview
o Exhibit 152: Sanofi SA - Business segments
o Exhibit 153: Sanofi SA - Key news
o Exhibit 154: Sanofi SA - Key offerings
o Exhibit 155: Sanofi SA - Segment focus
o 12.14 Shijiazhuang Yiling Pharmaceutical Co Ltd.
o Exhibit 156: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Overview
o Exhibit 157: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Product / Service
o Exhibit 158: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Key offerings
o 12.15 SK Chemicals Co. Ltd.
o Exhibit 159: SK Chemicals Co. Ltd. - Overview
o Exhibit 160: SK Chemicals Co. Ltd. - Business segments
o Exhibit 161: SK Chemicals Co. Ltd. - Key offerings
o Exhibit 162: SK Chemicals Co. Ltd. - Segment focus
o 12.16 Vaccitech Plc
o Exhibit 163: Vaccitech Plc - Overview
o Exhibit 164: Vaccitech Plc - Product / Service
o Exhibit 165: Vaccitech Plc - Key offerings
o 12.17 Vaxart Inc.
o Exhibit 166: Vaxart Inc. - Overview
o Exhibit 167: Vaxart Inc. - Product / Service
o Exhibit 168: Vaxart Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 169: Inclusions checklist
o Exhibit 170: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 171: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 172: Research methodology
o Exhibit 173: Validation techniques employed for market sizing
o Exhibit 174: Information sources
o 13.5 List of abbreviations
o Exhibit 175: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global influenza vaccine market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals and pharmacies - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals and pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Government and institutional - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Government and institutional - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Government and institutional - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Government and institutional - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Live attenuated influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Live attenuated influenza vaccines - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Recombinant influenza vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Recombinant influenza vaccines - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Type ($ million)
Exhibits61: Data Table on Market opportunity by Type ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Altimmune Inc. - Overview
Exhibits112: Altimmune Inc. - Product / Service
Exhibits113: Altimmune Inc. - Key news
Exhibits114: Altimmune Inc. - Key offerings
Exhibits115: AstraZeneca PLC - Overview
Exhibits116: AstraZeneca PLC - Product / Service
Exhibits117: AstraZeneca PLC - Key news
Exhibits118: AstraZeneca PLC - Key offerings
Exhibits119: Baxter International Inc. - Overview
Exhibits120: Baxter International Inc. - Business segments
Exhibits121: Baxter International Inc. - Key news
Exhibits122: Baxter International Inc. - Key offerings
Exhibits123: Baxter International Inc. - Segment focus
Exhibits124: BiondVax Pharmaceuticals Ltd. - Overview
Exhibits125: BiondVax Pharmaceuticals Ltd. - Product / Service
Exhibits126: BiondVax Pharmaceuticals Ltd. - Key offerings
Exhibits127: CSL Ltd. - Overview
Exhibits128: CSL Ltd. - Business segments
Exhibits129: CSL Ltd. - Key news
Exhibits130: CSL Ltd. - Key offerings
Exhibits131: CSL Ltd. - Segment focus
Exhibits132: FluGen Inc. - Overview
Exhibits133: FluGen Inc. - Product / Service
Exhibits134: FluGen Inc. - Key offerings
Exhibits135: GlaxoSmithKline Plc - Overview
Exhibits136: GlaxoSmithKline Plc - Business segments
Exhibits137: GlaxoSmithKline Plc - Key news
Exhibits138: GlaxoSmithKline Plc - Key offerings
Exhibits139: GlaxoSmithKline Plc - Segment focus
Exhibits140: Mitsubishi Chemical Group Corp. - Overview
Exhibits141: Mitsubishi Chemical Group Corp. - Business segments
Exhibits142: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits143: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits144: Novavax Inc. - Overview
Exhibits145: Novavax Inc. - Product / Service
Exhibits146: Novavax Inc. - Key offerings
Exhibits147: Pfizer Inc. - Overview
Exhibits148: Pfizer Inc. - Product / Service
Exhibits149: Pfizer Inc. - Key news
Exhibits150: Pfizer Inc. - Key offerings
Exhibits151: Sanofi SA - Overview
Exhibits152: Sanofi SA - Business segments
Exhibits153: Sanofi SA - Key news
Exhibits154: Sanofi SA - Key offerings
Exhibits155: Sanofi SA - Segment focus
Exhibits156: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Overview
Exhibits157: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Product / Service
Exhibits158: Shijiazhuang Yiling Pharmaceutical Co Ltd. - Key offerings
Exhibits159: SK Chemicals Co. Ltd. - Overview
Exhibits160: SK Chemicals Co. Ltd. - Business segments
Exhibits161: SK Chemicals Co. Ltd. - Key offerings
Exhibits162: SK Chemicals Co. Ltd. - Segment focus
Exhibits163: Vaccitech Plc - Overview
Exhibits164: Vaccitech Plc - Product / Service
Exhibits165: Vaccitech Plc - Key offerings
Exhibits166: Vaxart Inc. - Overview
Exhibits167: Vaxart Inc. - Product / Service
Exhibits168: Vaxart Inc. - Key offerings
Exhibits169: Inclusions checklist
Exhibits170: Exclusions checklist
Exhibits171: Currency conversion rates for US$
Exhibits172: Research methodology
Exhibits173: Validation techniques employed for market sizing
Exhibits174: Information sources
Exhibits175: List of abbreviations